Cytek Biosciences, Inc. (CTKB)

NASDAQ: CTKB · Real-Time Price · USD

5.84

+0.32 (5.80%)

At close: Nov 13, 2026, 4:00 PM EST

5.84

0.00 (0.00%)

After-hours: Nov 13, 2026, 4:15 PM EST

Cytek Biosciences Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	207.65	201.49	200.45	193.02	164.04	127.95
Revenue Growth	5.50%	0.52%	3.85%	17.67%	28.20%	37.82%
Gross Profit	110.89	104.46	111.11	109.43	100.97	79.14
Operating Income	-46.68	-40.38	-20.52	-27.85	-1.8	9.16
Net Income	-81.2	-66.54	-6.02	-12.15	2.58	0.05
Earnings Per Share	-0.63	-0.52	-0.05	-0.09	0.02	0.00
EPS Growth	-	-	-	-	2906.28%	-99.36%

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
United States	108.58	95.25	92.61	102.09	94.59	72.72
EMEA	54.2	55.88	62.34	53.18	43.96	36.97
APAC	37.15	41.08	35.77	31.6	22.52	16.08
Other	7.72	9.28	9.73	6.15	2.96	2.18
Total	207.65	201.49	200.45	193.02	164.04	127.95

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	255.9	261.53	277.86	262.41	341.15	364.62
Total Debt	24.69	23.74	17.02	14.14	18.09	-
Net Cash (Debt)	231.21	237.79	260.85	248.27	323.06	364.62
Net Cash Growth	-2.40%	-8.84%	5.06%	-23.15%	-11.40%	124.44%
Net Cash Per Share	1.79	1.86	2.00	1.84	2.33	4.47

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-6.59	-4.69	25.38	5.28	-12.23	4.63
Capital Expenditures	-6.89	-4.08	-3.53	-4.65	-9.75	-4.36
Free Cash Flow	-13.48	-8.77	21.85	0.63	-21.98	0.27
Free Cash Flow Growth	-	-	3352.45%	-	-	-98.05%

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	53.40%	51.84%	55.43%	56.69%	61.56%	61.86%
Operating Margin	-22.48%	-20.04%	-10.24%	-14.43%	-1.10%	7.16%
Pretax Margin	-19.24%	-14.81%	-2.84%	-8.14%	0.77%	4.64%
Profit Margin	-39.10%	-33.02%	-3.00%	-6.29%	1.57%	0.04%
FCF Margin	-6.49%	-4.35%	10.90%	0.33%	-13.40%	0.21%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	-	-	534.49	41969.36
Forward PE	-	89.56	26.14	245.06	44.39	152.95
P/FCF Ratio	-	-	38.25	1952.94	-	8204.54
PS Ratio	3.67	3.21	4.17	6.41	8.39	17.06